Cuadernos de Medicina Forense

16 CUADERNOS DE MEDICINA FORENSE AS O C I AC I Ó N D E M É D I C O S FO R E N S ES D E A N DA LU C Í A S O C I E DA D A N DA LU Z A D E M E D I C I N A L EG A L Y C I E N C I AS FO R E N S ES ( A M FA- SA M E LC I F ) MSC POR SÍNDROME DE KOUNIS Garamendi PM, et al. Cuad Med Forense. 2025; 28(2):9- 16 BIBLIOGRAFÍA 1. Kounis NG, Zavras GM. Histamine-induced coro- nary artery spasm: the concept of allergic angina. Br J Clin Pract 1991;45:121–8. 2. Kouinis NG. Kounis syndrome: an update on epi- demiology, pathogenesis, diagnosis and thera- peutic management. Clin Chem Lab Med 2016; 54(10): 1545–1559 3. Molina P, Presentación C, Beltrán P, Zorio E. Síndrome de Kounis: una posibilidad a tener en cuenta como causa de muerte súbita cardiaca. Cuad Med Forense.2012;18(1):35-38 4. Navarro-Escayola E, Canos-Villena JC. Protocolo de actuación en muerte súbita por anafilaxia. Rev Esp Med Legal.2011;37(1):37-45 5. Kovanen PT, Kaartinen M, Paavonen T. Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction. Circulation 1995;92:1083–8. 6. Biteker M, Duran NE, Biteker FS, Civan HA, Kaya H, Gökdeniz T, et al. Allergic myocardial infarc - tion in childhood: Kounis syndrome. Eur J Pediatr 2010;169:27–9. 7. Lippi G, Buonocore R, Schirosa F, Cervellin G. Cardiac troponin I is increased in patients admi- tted to the emergency department with severe allergic reactions. A case-control study. Int J Car- diol 2015;194:68–9. 8. Forzese E, Pitrone C, Cianci V et al. An Insight into Kounis Syndrome: Bridging Clinical Knowledge with Forensic Perspectives. Life 2024, 14, 91. DOI: https://doi.org/10.3390/life14010091 9. Li J, Zheng J, Zhou Y et al. Acute coronary syn- drome secondary to allergic coronary vasospasm (Kounis Syndrome): a case series, follow-up and literature review. BMC Cardiovasc Dis.2018;18:42 10. Pejcic AV, Milosavljevic MN, Jankovic S et al. Kounis Syndrome Associated With the Use of Di- clofenac. Texas Heart Inst J.2023;50(1):e217802.. DOI: https://doi.org/10.14503/THIJ-21-7802 11. Garcipérez de Vargas FJ, Mendoza J, Sánchez-Cal- derón P et al. Shock cardiogénico secundario a síndrome de Kounis tipo II inducido por metami- zol. Rev Esp Cardiol. 2012;65(12):1134–1142 12. Cianci V, Pitrone C, Sapienza D et al. Fatal Out- come Due to Kounis Syndrome Following Fluo- rescein Retinal Angiography: A Case Report. Diagnostics 2024, 14, 1092. DOI: https://doi. org/10.3390/diagnostics14111092 13. Di Filippo Ch, Giovannini M, Gentile S et al. Kounis Syndrome Associated With Takotsubo Syndrome in an Adolescent With Peutz-Jeghers Syndrome. JACC:Case Reports.2021;3(14):1602 – 1606. 14. Pejcic AV, Milosavljevic MN, Jankovic S et al. Kou - nis Syndrome Associated With the Use of Diclo- fenac. Tex Heart Inst J. 2023 Feb 3;50(1):e217802. 15. Baillieau F. Inmunoglobulina E: revisión y actua- lización de su rol en salud y enfermedad. Arch Alerg Inmunol Clin.2015;46(2):54-66 16. Edston E et al. Mast cell tryptase in postmortem serum. Reference values and confounders. Int J Legal Med. 2007;121:275-280. 17. Palmiere C et al. Measurement of b-tryptase in postmortem serum in cardiac deaths. J Forensic Legal Med.2014;23:12-18. 18. Garland J, Ondruschka B, Da Broi U, Palmiere C, Tse R, Post mortem tryptase: A review of literatu- re on its use, sampling and interpretation in the investigation of fatal anaphylaxis. Forensic Sci Med Pathol.2020;314:110415. Si desea citar nuestro artículo: Garamendi PM, Martínez de Mandojana AM, Mendoza J, Barrero F, Galisteo L, BarqueroM, et al. Muerte súbita cardíaca por síndrome de Kounis tipo II. Cuad Med Forense. 2025; 28(2): 9- 16. DOI: 10.59457/cmf.2025.28.02.cc01